Go to industries

Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
Worldwide
556
deals closed in Healthcare
Worldwide
Explore all our industry-related deals
Go to deals
Probiomed has been acquired by Sanfer
Private Equity | Healthcare

Probiomed has been acquired by Sanfer

The shareholders of Probiomed S.A. de C.V. have sold the company to Laboratorios Sanfer.

Learn more
“Engaging Oaklins noticeably accelerated and advanced our succession process. The team managed it consistently and proactively and ensured that we had several attractive options available until the very end. This resulted in an outcome that exceeded our expectations.”

Dr. Herbert Wegmüller and Dr. Thierry Littmann

Owners, Röntgeninstitut Aarau

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=MX&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Growth and continuity shape Q3 transactions

QUARTERLY M&A ACTIVITY: In Q3 2026, Oaklins clients closed 67 deals across M&A and fundraising, with buyers seeking expertise, customer relationships and new market access.

Learn more

Talk to us

Andrei Lepiavka

Managing Partner
Mexico City, Mexico
Oaklins Mexico